Search results: Sage Journals

Restricted accessCase reportFirst published June, 2023

Hypernatremia and hypokalemia with Entrectinib therapy: A case of possible nephrogenic diabetes insipidus

Remy Fadel, Jad Tabbara, Anne Huml [...]

Journal of Onco-Nephrology

Open accessResearch articleFirst published February, 2025

Withdrawal pain following patients discontinuing Trk inhibitors

Alan Chin, Sheila Lindsay, Emily K Bergsland [...]

Journal of Oncology Pharmacy Practice

Restricted accessArticle commentaryFirst published December, 2020

Neurotrophic tyrosine kinase inhibitors: A review of implications for patients,clinicians and healthcare services

Andrew Walker

Journal of Oncology Pharmacy Practice

Open accessResearch articleFirst published October, 2025

Hepatotoxicity of ALK/ROS1 tyrosine kinase inhibitors in non-small cell lung cancer patients: A pharmacovigilance study based on signal mining and analysis of the FDA adverse event reporting system database

Weixing Zhao, Xiaoni Jin, Yuan Li [...]

Science Progress

Open accessCase reportFirst published 2025

Identification of a novel PRUNE2::NTRK2 gene fusion in soft tissue sarcoma patients—friend or foe? Case series

Klaudia Bobak, Andrzej Tysarowski, Katarzyna A. Seliga [...]

Therapeutic Advances in Medical Oncology

Free accessReview articleFirst published January, 2016

ALK inhibitors in non-small cell lung cancer: the latest evidence and developments

Ivana Sullivan, David Planchard

Therapeutic Advances in Medical Oncology

Restricted accessResearch articleFirst published February, 2024

Multitarget Potential Drug Candidates for High-Grade Gliomas Identified by Multiple Reaction Monitoring Coupled with In Silico Drug Repurposing

Ayushi Verma, Rushda Patel, Atharva Mahale [...]

OMICS: A Journal of Integrative Biology

Free accessResearch articleFirst published August, 2023

Pan-TRK immunohistochemistry as screening tool for NTRK fusions: A diagnostic workflow for the identification of positive patients in clinical practice

Andrea Vingiani, Daniele Lorenzini, Elena Conca [...]

Cancer Biomarkers

Open accessCase reportFirst published 2023

TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis

Arielle J. Medford, Lauren Oshry, Baris Boyraz [...]

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published 2024

Identification of Hub of the Hub-Genes From Different Individual Studies for Early Diagnosis,Prognosis,and Therapies of Breast Cancer

Md Shahin Alam, Adiba Sultana, Md Kaderi Kibria [...]

Bioinformatics and Biology Insights

Restricted accessCase reportFirst published June, 2023

Hypernatremia and hypokalemia with Entrectinib therapy: A case of possible nephrogenic diabetes insipidus

Remy Fadel, Jad Tabbara, Anne Huml [...]

Journal of Onco-Nephrology

Open accessResearch articleFirst published February, 2025

Withdrawal pain following patients discontinuing Trk inhibitors

Alan Chin, Sheila Lindsay, Emily K Bergsland [...]

Journal of Oncology Pharmacy Practice

Restricted accessArticle commentaryFirst published December, 2020

Neurotrophic tyrosine kinase inhibitors: A review of implications for patients,clinicians and healthcare services

Andrew Walker

Journal of Oncology Pharmacy Practice

Open accessResearch articleFirst published October, 2025

Hepatotoxicity of ALK/ROS1 tyrosine kinase inhibitors in non-small cell lung cancer patients: A pharmacovigilance study based on signal mining and analysis of the FDA adverse event reporting system database

Weixing Zhao, Xiaoni Jin, Yuan Li [...]

Science Progress

Open accessCase reportFirst published 2025

Identification of a novel PRUNE2::NTRK2 gene fusion in soft tissue sarcoma patients—friend or foe? Case series

Klaudia Bobak, Andrzej Tysarowski, Katarzyna A. Seliga [...]

Therapeutic Advances in Medical Oncology

Free accessReview articleFirst published January, 2016

ALK inhibitors in non-small cell lung cancer: the latest evidence and developments

Ivana Sullivan, David Planchard

Therapeutic Advances in Medical Oncology

Restricted accessResearch articleFirst published February, 2024

Multitarget Potential Drug Candidates for High-Grade Gliomas Identified by Multiple Reaction Monitoring Coupled with In Silico Drug Repurposing

Ayushi Verma, Rushda Patel, Atharva Mahale [...]

OMICS: A Journal of Integrative Biology

Free accessResearch articleFirst published August, 2023

Pan-TRK immunohistochemistry as screening tool for NTRK fusions: A diagnostic workflow for the identification of positive patients in clinical practice

Andrea Vingiani, Daniele Lorenzini, Elena Conca [...]

Cancer Biomarkers

Open accessCase reportFirst published 2023

TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis

Arielle J. Medford, Lauren Oshry, Baris Boyraz [...]

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published 2024

Identification of Hub of the Hub-Genes From Different Individual Studies for Early Diagnosis,Prognosis,and Therapies of Breast Cancer

Md Shahin Alam, Adiba Sultana, Md Kaderi Kibria [...]

Bioinformatics and Biology Insights